Skip to content
Open access

Phytochemical Profiling, In-Vitro COX-2 Inhibition and In-Silico Evaluation of the Ethanolic Flower Extract of Rosa indica L.

Oct 2026 · International Journal of Drug Delivery Technology · 0 citations

Abstract

Background: Pain and inflammation are leading reasons for medical care, and the adverse effects of long-term NSAID and opioid use sustain interest in safer plant-derived alternatives. Rosa indica L. (Rosaceae) is traditionally used for wounds, headaches, and inflammatory complaints, but its anti-inflammatory mechanism remains poorly defined. Objective: To chemically characterise the ethanolic flower extract of Rosa indica and evaluate its COX-2 inhibitory potential using integrated in vitro and in silico approaches. Methods: Fresh authenticated flowers were cold-macerated in 95 % ethanol and concentrated below 40°C. The extract underwent qualitative phytochemical screening, GC–MS profiling and a concentration-dependent COX-2 inhibition assay with indomethacin as a standard. Major constituents were docked against COX-2 (PDB: 5IKR), assessed for drug-likeness, and the resulting complexes were subjected to RMSF analysis using CABS-flex 3.0. Results: Screening confirmed phenolics, flavonoids, alkaloids, tannins, saponins, steroids and glycosides. GC–MS identified 27 constituents, including pyrogallol, 2,4-di-tert-butylphenol, 5-hydroxymethylfurfural, DDMP, phenylethyl alcohol, vanillin lactoside, linoleic acid, and chondroitin sulfate. Ethanolic extract of Rosa indica inhibited COX-2 with an IC₅₀ of 624.5 ± 23.33 µg/mL, compared with 93.35 ± 0.88 % inhibition by indomethacin. Docking energies ranged from −7.0 to −8.7 kcal/mol, led by vanillin lactoside (−8.7) and chondrillasterol (−8.3). Phenylethyl alcohol and 2,4-di-tert-butylphenol showed was most drug-like lead strongest binders were least drug-like. RMSF values remained largely below 1.5 Å. Conclusion: The ethanolic flower extract of Rosa indica is a weak to moderate, multi-component COX-2 inhibitor whose activity most likely reflects additive contributions of phenolic, glycosidic, fatty acid, as well as steroidal constituents. These findings provide a mechanistic rationale for the traditional anti-inflammatory use of the plant and justify bioassay-guided fractionation and in-vivo validation, but do not by themselves establish therapeutic efficacy.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.